0001185185-18-002160.txt : 20181211 0001185185-18-002160.hdr.sgml : 20181211 20181210182238 ACCESSION NUMBER: 0001185185-18-002160 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 8 CONFORMED PERIOD OF REPORT: 20181017 ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20181211 DATE AS OF CHANGE: 20181210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: True Nature Holding, Inc. CENTRAL INDEX KEY: 0000802257 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATIONS EQUIPMENT, NEC [3669] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-53601 FILM NUMBER: 181227381 BUSINESS ADDRESS: STREET 1: 1355 PEACHTREE STREET STREET 2: SUITE 1150 CITY: ATLANTA STATE: GA ZIP: 30309 BUSINESS PHONE: 404-254-6980 MAIL ADDRESS: STREET 1: 1355 PEACHTREE STREET STREET 2: SUITE 1150 CITY: ATLANTA STATE: GA ZIP: 30309 FORMER COMPANY: FORMER CONFORMED NAME: Trunity Holdings, Inc. DATE OF NAME CHANGE: 20120125 FORMER COMPANY: FORMER CONFORMED NAME: BRAIN TREE INTERNATIONAL INC DATE OF NAME CHANGE: 19860922 8-K 1 truenat20181210_8k.htm FORM 8-K truenat20181210_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event Reported): October 17, 2018

 

TRUE NATURE HOLDING, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-53601

 

87-0496850

(State or other Jurisdiction of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1355 Peachtree Street, Suite 1150

Atlanta, GA 30309

(Address of Principal Executive Offices) (Zip Code)

 

(844) 383-8689

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company   ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Resignation of Director and Chief Operating Officer

 

On December 2, 2018, Louis DeLuca submitted his resignation from his positions with True Nature Holding, Inc., a Delaware corporation (the “Company”) as a member of the Board of Directors (the “Board”) and Chief Operating Officer, effective December 4, 2018. Mr. DeLuca did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company and its shareholders thank Mr. DeLuca for his many contributions. Mr. DeLuca will continue working with the Company as a business operations consultant to ensure an efficient transition.

 

Appointment of Chairman of the Board of Directors

 

Ronald Riewold, age 71, Chairman of the Board of Directors

 

Effective November 27, 2018, Mr. Ronald Riewold was appointed to the Board, as its Chairman (the “Chairman Appointment”).

 

Mr. Riewold will receive compensation for his Board service in the form of an issuance of 100,000 shares of restricted common stock of the Company (the “Common Stock”), valued at $0.10 per share, for a total charge to earnings of $10,000. In addition to Mr. Riewold’s duties as Chairman of the Board, the Company has engaged Mr. Riewold as a consultant to assist with strategic financing. In this consulting role Mr. Riewold will be compensated at $100 per hour plus prior approved expenses, not to exceed 20 hours per week.

 

Mr. Riewold has extensive experience in operating and developing both public and private companies. Specifically, his expertise is in field and practice-level health care company operations. Mr. Riewold is a former executive of six companies since 1978, three in the finance and real estate sectors, and three in the health care and technology sectors. Mr. Riewold has completed multiple mergers in the health care industry.

 

In 2001, Mr. Riewold joined Pain Care Holdings as one of its original investors, President, Co-Chief Executive Officer and member of the Board of Directors. Mr. Riewold helped Pain Care Holdings rise from a start-up to a multi-million-dollar company that developed processes that monitor patients including residents in nursing homes, rehabilitation facilities and hospitals. In 2008, Mr. Riewold started Dynamic Real Estate Development as Chief Executive Officer focusing on development of medical buildings while partnering with physician groups and providing expertise as a fee developer. From 2011 to the present, Mr. Riewold founded and is President and Chief Executive Officer of Averlent Corporation, a national medication management initiative.

 

Mr. Riewold earned a bachelor’s degree from Florida State University 1970, and a Master of Business Administration from Temple University, 1972.

 

There is no arrangement or understanding between Mr. Riewold and any other persons pursuant to which Mr. Riewold was selected as an officer. There are no family relationships between Mr. Riewold and any director, executive officer or person nominated or chosen by the Company to become a director or executive officer of the Company within the meaning of Item 401(d) of Regulation S-K under the U.S. Securities Act of 1933 (“Regulation S-K”). Since the beginning of the Company’s last fiscal year, the Company has not engaged in any transaction in which Mr. Riewold had a direct or indirect material interest within the meaning of Item 404(a) of Regulation S-K.

 

Appointment of Chief Revenue Officer and Member of the Board of Directors

 

Mark Williams, age 58, Chief Revenue Officer and Member of the Board of Directors

 

Effective November 27, 2018 (the “Effective Date”), Mr. Mark Williams was appointed as Chief Revenue Officer of the Company (the “CRO Appointment”). In connection with the CRO Appointment, Mr. Williams and the Company entered into an Employment Agreement (the “Williams Employment Agreement”), pursuant to which Mr. Williams’ compensation shall consist of (i) a base salary of $100,000 per year that shall accrue and be paid only upon sufficient funding to the Company, as determined by the Board (the “Base Salary”); (ii) a potential performance bonus, subject to approval by the Board, of up to 100% of the Base Salary; and (iii) a grant of 500,000 shares of Common Stock subject to certain vesting requirements, valued at $0.10 per share, resulting in a charge to Company earnings of $50,000.

 

 

 

 

Additionally, on the Effective Date Mr. Williams was appointed to the Board (the “Director Appointment”). Mr. Williams will be compensated for his Board service in the form of an issuance of 100,000 shares of Common Stock, valued at $0.10 per share, for a total charge to earnings of $10,000.

 

From 2008 through 2016, Mr. Williams was the founder, President and CEO of Artistry Consulting (“Artistry”), a technology consulting firm specializing in healthcare technology, working with large healthcare providers and insurers across the US, Canada, UK, UAE, and Egypt. Having established strategic relationships with Allscripts, Cerner, Epic and Siemens Medical, Mr. Williams built Artistry to $26,856,000 in annual revenue with clients including Dignity Health, Bon Secours Health System, CHI, The Cambridge Institute, the UAE Ministry of Health and SEHA. In 2016, the firm was sold to a UAE-based conglomerate. Since 2017, Mr. Williams was a partner and senior professional services consultant at Altus Alliance, an international revenue growth services firm, specializing in accelerating success through top-line revenue growth in new ventures within large companies and technology startups. At Altus, Williams was part of a team that worked with over 200 companies, assisted in successful initial public offerings and other corporate transactions, and worked directly for client companies through business development and sales. Additionally, during 2016 and continuing into 2017, Mr. Williams also served as a Director for the Washington Medical Information Network and was Senior Vice President of Orion Health overseeing professional services. Mr. Williams served as the Programs Chair for the Health Information Management Systems Society, is a Senior Advisor for Spadafy and is an Advisor to the University of St. Augustine program for Health Sciences in entrepreneurship and technology programs. Mr. Williams holds degrees in Business and Engineering from the University of Utah, 1985.

 

There is no arrangement or understanding between Mr. Williams and any other persons pursuant to which Mr. Williams was selected as an officer. There are no family relationships between Mr. Williams and any director, executive officer or person nominated or chosen by the Company to become a director or executive officer of the Company within the meaning of Item 401(d) of Regulation S-K under the U.S. Securities Act of 1933 (“Regulation S-K”). Since the beginning of the Company’s last fiscal year, the Company has not engaged in any transaction in which Mr. Williams had a direct or indirect material interest within the meaning of Item 404(a) of Regulation S-K.

 

The above description of the Williams Employment Agreement does not purport to be complete and is qualified in its entirety by the full text of the Williams Employment Agreement, which is attached hereto as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

On October 17, 2018, the Company issued 584,420 shares of Common Stock to an advisor or his designee in consideration for consulting services. The Company values these shares at $0.10 per share for a total charge to earnings of $58,442.

 

On October 24, 2018, the Company issued 105,820 shares of Common Stock to an advisor or his designee in consideration for consulting services. The Company values these shares at $0.10 per share for a total charge to earnings of $10,582.

 

On November 3, 2018, the Company appointed a new member to its Advisory Board (the “Advisory Board Appointment”). In connection with the Advisory Board Appointment 100,000 shares of Common Stock were issued to Mr. John Stowell as compensation for his contributions to the Company. The Company values these shares at a price of $0.10 per share for a total charge to earnings of $10,000.

 

On November 27, 2018, the Company issued 100,000 shares of Common Stock to an advisor or his designee in consideration for consulting services regarding acquisitions. The Company values these shares at $0.10 per share for a total charge to earnings of $10,000.

 

On November 27, 2018, in connection with the Chairman appointment and the Director Appointment, the Company issued 100,000 shares of Common Stock valued at $0.10 per share to each of Ronald Riewold and Mark Williams for a total charge to earnings of $20,000.

 

On November 27, 2018, in connection with the CRO Appointment, the Company issued 500,000 shares of Common Stock, subject to certain vesting requirements, to Mark Williams. The Company values these shares at $0.10 per share for a total charge to earnings of $50,000.

 

 

 

 

The issuance of the securities set forth herein was made in reliance on the exemption provided by Section 4(a)(2) of the Securities Act for the offer and sale of securities not involving a public offering. The Company’s reliance upon Section 4(a)(2) of the Securities Act in issuing the securities was based upon the following factors: (a) the issuance of the securities was an isolated private transaction by us which did not involve a public offering; (b) there were only five recipients; (c) there were no subsequent or contemporaneous public offerings of the securities by the Company; (d) the securities were not broken down into smaller denominations; and (e) the negotiations for the issuance of the securities took place directly between the individual and the Company.

 

Item 7.01 Regulation FD Disclosure.

 

On November 15, 2018, the Company issued a press release announcing the appointment of a consumer and digital marketer, Mr. John Stowell, to the Advisory Board. See Exhibit 99.1 for more information.

 

On December 4, 2018, the Company issued a press release announcing the appointment of Mr. Ronald Riewold as Chairman of its Board of Directors. See Exhibit 99.2 for more information.

 

The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, and Exhibit 99.2 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing by the Company under the Securities Act.

 

Item 8.01 Other Events.

  

Appointment of a Member of the Advisory Board 

 

The Company's Advisory Board (the “Advisory Board”) consists of experts in certain areas relevant to the Company’s operations. The members of the Advisory Board have no control over the Board or operations and as such are not subject to Section 16 of the Securities Exchange Act of 1934, as amended.

 

On November 3, 2018, the Board announced the appointment of Mr. John Stowell to the Advisory Board.

 

Mr. Stowell, 56, is a consumer and digital marketing expert, having developed new brands and products for leading companies in both B2B and B2C markets. Mr. Stowell launched Gold Peak RTD Tea and other consumer brands while employed at the Coca-Cola Company. Mr. Stowell also restaged two mature brands generating four percentage point or greater increases in sales for Nestea and Mitsubishi Electric Cooling and Heating. Mr. Stowell has successfully launched over a dozen product lines extensions ranging in size from $10M to over $50M for companies including H.J. Heinz and Zep Inc.

 

Mr. Stowell is currently a Doctor of Business Administration candidate at Georgia State University, expected 2019. Mr. Stowell earned his Master of Business Administration in marketing from The University of North Carolina, 1990 and a Bachelor of Economics from the University of Oklahoma, 1984.

 

Mr. Stowell will receive compensation for his Advisory Board service to the Company in the form of an issuance of 100,000 shares of Common Stock, valued at $0.10 per share.

 

Item 9.01 Exhibits

 

Exhibit
Number

 

Description

10.1*

 

Senior Executive Employment Agreement by and between True Nature Holding Inc. and Mark Williams, dated November 27, 2018

99.1*

 

Press Release dated November 15, 2018, announcing the appointment of John Stowell to the Advisory Board

99.2*

 

Press Release dated December 4, 2018, announcing the appointment of Ronald Riewold as Chairman of the Board of Directors

 

*Filed herewith

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TRUE NATURE HOLDING INC.

 

 

 

 

Dated: December 10, 2018

By:

/s/ James Crone

 

Name:

James Crone

 

Title:

President and Interim Chief Financial Officer 

 

 

 

 

EX-10.1 2 ex_131449.htm EXHIBIT 10.1 ex_131449.htm

 

Exhibit 10.1

 

 

TRUE NATURE HOLDING, INC.

SENIOR EXECUTIVE EMPLOYMENT AGREEMENT

 

This Agreement is made as of the 27 day of November 2018, between the TRUE NATURE HOLDING, INC. a publicly traded company incorporated in the State of Delaware (“Employer”), and Mr. Mark Williams, residing at 3020 Issaquah Pine Lake Road #234 Sammamish, WA 98075 (“Employee”).

 

WHEREAS, the Employer, the authorized representative of the Employer, desires to employ Mark Williams as the Chief Revenue Officer of the Employer; and

 

WHEREAS, the parties have reached an agreement as to the terms of said employment as more fully set forth in this Agreement.

 

NOW, THEREFORE, in consideration of the promises and the mutual covenants, terms and conditions as hereinafter set forth, the parties hereby agree as follows:

 

 

1.

Nature of Services and Duties.

 

a.     Effective 27 November 2018, Employee shall serve in the position of Chief Revenue Officer.

 

b.     At all times during the term of this Agreement, Employee shall use his/her best efforts and apply his/her skill and experience to the proper performance of his/her duties hereunder and to achieve the goals set forth

herein. Employee shall be directly accountable to and work under the authority and direction of the Chief Executive Officer (“CEO”), or any “Designee” the CEO shall direct the Employee to report to and shall report through such offices as may be directed by the CEO, or their Designee, from time to time. Employee shall perform such executive, managerial and administrative duties and services as are customary for a True Nature Holding, Inc. and such further executive duties as may be specified from time to time by the CEO, or their Designee, including without limitation:

 

i.     Chief Revenue Officer is a pivotal leadership role directly influencing the future of the company. Your responsibilities will include acquisition strategy development, market product development, new business sales, installed client base sales, marketing, and partner strategy in related fields and or others when requested by the CEO or Board of Directors.

 

ii.     As TNTY’s Chief Revenue Officer, utilize your successful background of scaling revenues quickly with a target of tens and hundreds of millions over the next five years. As well as leverage and create relationships among Fortune 1000 brands, and direct/managing potentially a large TNTY healthcare solution-focused organization.

 

iii.     Given TNTY’s is public early phase developing company, your contributions toward and collaboration with other senior leaders in organizational development is key to ensure success.

 

 

2.

Term.

 

This Agreement shall be effective from 27 November 2018, (“the Commencement Date”), through employees’ resignation and or unless amended by subsequent written agreement of the parties or terminated as provided

herein. The Employee shall be considered a full-time employee as of the Commencement Date and will serve at the will of the CEO.

 

 

1

 

 

 

 

3.

Compensation.

 

(a)     Employee shall be paid an annual base salary of One Hundred Thousand ($100,000) Dollars payable in accordance with the Employer’s standard payroll procedures, with a performance and salary review to be conducted annually, at which time the Employee’s salary shall be adjusted in accordance with applicable compensation policies.

 

(b)     In addition, Employee shall be eligible to receive a bonus target of 100% of base compensation commencing fiscal year 2019, if approved by the Compensation Committee in its sole discretion.

 

(c)     The Employee agrees that their Compensation will accrue from the Commencement Date of this agreement until such time as the Company, as determined by the Board, has sufficient funding.

 

(d)     The Employee may receive certain grants of Restricted Common Stock, and those grants may be subject to certain vesting, or reverse vesting, conditions, including, but not limited to the tenure of the Employee, or achievement of certain objectives, as further defined in a Restricted Stock Grant Agreement, and generally under the terms as noted below:

 

 

1.

Grant of Restricted Stock. True Nature Holding, Inc. (the “Company”) hereby grants to Grantee an Award of shares of Restricted Common Stock of the Company (collectively, the “Restricted Stock”) pursuant to reverse vesting terms. The Restricted Stock granted pursuant to the Award shall be immediately issued in an escrow account the name of the Grantee and released as reverse vesting expires. Any unearned Restricted Stock granted shall be cancelled in the event the Employee is terminated by the Employer.

 

 

2.

Vesting is as follows:

 

a)     100,000 shares once the Employee has been with the Employer for 90 days from the effective date of this agreement;

 

b)     100,000 restricted stock shares once the Employer completes a capital raise of $2,000,000;

 

c)     100,000 restricted stock shares once the Employee has been with the Company for 365 days from the effective date of this agreement;

 

d)     100,000 restricted stock shares once the Employer files a 10K that reports $20,000,000 in Gross Revenue;

 

e)     100,000 restricted stock shares once the Employee has been with the Employer for 730 days from the effective date of this agreement;

 

f)     In the event of a change in control of the Company, any remaining unvested shares will immediately vest upon change of control of the Company.

 

 

3.

Restrictions on Transfer.

 

The Shares of Restricted Stock issued under this Agreement may not be sold, transferred or otherwise disposed of and may not be pledged or otherwise hypothecated until all restrictions on such Restricted Stock shall have lapsed. The shares are subject to certain reverse vesting terms and can only be release with an opinion of company counsel.

 

 

4.

Termination.

 

Employee’s employment hereunder may be terminated by Employer under the following circumstances:

 

(a)     at the recommendation of the CEO with approval by the Chairman of the Board of Directors;

 

 

2

 

 

 

(b)     upon any violations of the Securities laws;

 

(c)     Upon incapacity or inability to perform all the duties set forth in this Agreement due to mental or physical disability;

 

If Employee’s employment is terminated by virtue of any of the events described in paragraph (a), (b), or (c) Employee shall be entitled only to compensation though the date of such termination and any restricted stock grants that have not vested shall be cancelled.

 

 

5.

Confidentiality and Proprietary Information.

 

Employee acknowledges that he/she will be exposed to confidential information of the Employer, which includes confidential information of True Nature Holding, Inc., and other operations and activities. Confidential information includes, but is not limited to, data relating to the Employer’s operations, customer information, financial data, computer programs, architectural drawings, marketing plans and information, operating procedures and the like, or any other information of the business affairs of True Nature.

 

Employee shall not, directly or indirectly, use, disseminate, disclose, or in any way reveal or use beyond the scope of authority granted by the Employer all or any part of such Confidential Information, which he/she has been or will be exposed to, and shall use such Confidential Information only to the extent specifically authorized by the Employer.

 

Upon termination of this Agreement for any reason whatsoever, Employee shall turn over to the Employer all Confidential Information. Employee acknowledges that the Employer may exercise any and all remedies available to it at law or in equity to enforce this Agreement with respect to non-disclosure of any Confidential Information, which Employee has or will become privy to in the performance of its obligations under this Agreement. The parties acknowledge that this provision shall survive the termination of the Agreement.

 

 

6.

Work Product

 

Any programs, systems, plans, software, hardware, devices, and ideas developed by Employee or anyone in the Employee’s Department during the period of Employee’s employment from the date of original hire shall be the exclusive property of the Employer.

 

 

7.

Covenant Not to Compete.

 

(a)     Employee agrees that during the terms of this Agreement he shall devote his full business time, energy, skill, labor, and attention to the affairs of the Employer and its affiliates or subsidiaries, shall promptly and faithfully do and perform all services pertaining thereto that are or may hereafter be required of him by the Employer, and shall not engage in any activities, directly or indirectly, involving a conflict of interest with the business or relations of the Employer or its affiliates or subsidiaries.

 

(b)     Employee recognizes that the business of the Employer and its affiliates or subsidiaries are national and international in scope and that the services to be performed hereunder and the methods employed by the Employer or its affiliates or subsidiaries are such as will place Employee in close business and personal relationship with competing businesses of the Employer or its affiliates or subsidiaries. Therefore, from and after the date of this Agreement and for one year after expiration of this Agreement or termination of this Agreement, Employee shall not, directly or indirectly, for his own benefit or for, with, or through any other person, company, or competitive company to Employer, within the states of Georgia own, manage consult, or be connected with, as owner, partner, joint venture, director, employee, officer, consultant, or in any other capacity whatsoever, engage in any business which is the same as, similar to or competitive with any business activities of the Employer. “Business” is defined as any healthcare systems, software, service or consulting activity.

 

 

3

 

 

 

Employee acknowledges that the restrictive covenants (the “Restrictive Covenants’) contained in this Section are a condition of his employment and are reasonable and valid in geographical and temporary scope and in all other respects. If any court determines that any Restrictive Covenants, or any part of the Restrictive Covenants, is invalid or unenforceable, the remainder of the Restrictive Covenants and parts thereof shall not thereby be affected and shall be given full effect, without regard to the invalid portion. If any court determines that any of the Restrictive Covenants, or any part thereof, is invalid and unenforceable because of geographic or temporal scope of such provision, such court shall have the power to reduce the geographic or temporal scope of such provision, as the case may be, and, in its reduced form, such provision shall then be enforceable.

 

(c)     If Employee breaches, or threatens to breach, any of the Restrictive Covenants, the Employer, in addition to and not in lieu of any other rights and remedies it may have at law or in equity, shall have the right to injunctive relief; it being acknowledged and agreed to by Employee that any such breach or threatened breach would cause irreparable and continuing injury to the Employer and that money damages would not provide an adequate remedy to the Employer.

 

 

8.

Miscellaneous.

 

(a)     Employee represents to Employer that there are no restrictions or agreements to which he is a party which would be violated by his execution of this Agreement and his employment hereunder.

 

(b)     No amendment or waiver of any provision of this Agreement shall be effective unless in writing signed by both parties.

 

(c)     Employee shall have no right to assign, transfer, pledge or otherwise encumber any of the rights, nor to delegate any of the duties created by this Agreement.

 

 

9.

Governing Law.

 

This Agreement is subject to and shall be interpreted in accordance with the laws of the State of Delaware. EXECUTED, as of the date first written above.

 

 

EMPLOYER: True Nature Holding, Inc.

 

 

By:                                                               

 

 

EMPLOYEE: Mr. Mark Williams

 

 

By:                                                               

 

 

 
4

 

 
EX-99.1 3 ex_131450.htm EXHIBIT 99.1 ex_131450.htm

 

Exhibit 99.1

 

  

 

 

True Nature Holding Inc. Appoints Consumer and Digital Marketing Expert to Advisory Board

 

Atlanta, GA - (NewMediaWire) - November 15, 2018 -  True Nature Holding, Inc. (OTCQB: TNTY) (the "Company" or "True Nature") announces the appointment of John S. Stowell, age 56, to its Board of Advisors. Mr. Stowell is a senior marketing leader with deep business management expertise at both large and entrepreneurial firms. His resume includes over 25 years of brand building marketing experience from notable companies including Coca-Cola, Mitsubishi Electric Heating and Cooling, as well as Zep Cleaning Solutions.   

 

“True Nature is committed to fully addressing the ‘direct to consumer’ movement in healthcare through technology offerings. The business solutions we are developing will assist healthcare professionals to establish longer-term relationships, better share information, and enable patients to better take control of their quality of life. Having a subject matter expert like John as an advisor to the management team helps us maximize shareholder value,” noted True Nature’s President Jim Crone.

 

Stowell’s experience includes new brand and product development for leaders in both B2C and B2B markets. He launched two consumer brands at the Coca-Cola Company, and one now exceeds over $1B in sales - Gold Peak RTD Tea. He also restaged two mature brands generating four percentage point sales increases for Nestea and Mitsubishi Electric Cooling and Heating. Stowell also launched over a dozen product line extensions ranging in size from $10M to $50M for companies including H.J. Heinz and Zep Inc.

 

Mr. Stowell commented, “As the healthcare field moves from a specialty area to more of a commodity, the communications between the provider and the end user becomes more important than ever in establishing, and maintaining, the relationship. We can use the same approach that a leader like Coke would, and greater enhance the relationship and accelerate the growth of the providers, all while causing the consumer to embrace the control of his own lifestyle and living quality.  I am excited to contribute toward True Nature Holding (TNTY) growth as an active advisor.”

 

Stowell is currently a Doctor of Business Administration candidate at Georgia State University, earned a Master of Business Administration in Marketing from the University of North Carolina, and Bachelor of Economics from the University of Oklahoma.

 

The Company's Advisory Board consists of experts in certain areas relevant to the Company’s operations. The members of the True Nature Holding, Inc. Board of Advisors have no control or decision-making capabilities over the Company’s operations and do not fall into the categories of people subject to Section 16 of the Securities Exchange Act of 1934, as amended.

 

 

 

 

The Mission of True Nature Holding, Inc.

 

To leverage new technologies and services to improve healthcare and outcome for individuals, their families, and their pets. We believe we can reduce the cost of healthcare while improving the quality of life using Telehealth and Telemedicine Solutions.

 

We are building healthcare applications that focus on patient engagement, care coordination, remote monitoring, data analytics, and may include Blockchain RX(TM) to provide applications for market participants in healthcare through the encryption of sensitive data.

 

Our approach is to develop these business opportunities as individual "threads" in response to client needs, ultimately creating an end-to-end set of solutions from the end user up to the healthcare provider, or veterinary professional. Further, we expect to assist suppliers to the healthcare industry by allowing them to access unique technologies that bind them with their clients in a "top-down" distribution model.

 

We recognize it will take the investment of major market participants like Apple, Amazon, IBM, hospitals, healthcare networks, pharmacy and other providers for us to achieve critical mass. In consideration of this reality, we expect to work with these market makers in collaboration, and in support of the ultimate user, the individual, and their pets. The day of "direct-to-consumer" healthcare, including "the humanization of our pets" is upon us, and we hope to be key parties to their evolution, and success.

 

Statement Under the Private Securities Litigation Reform Act

 

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release contains forward-looking statements pertaining to future, anticipated, or projected plans, performances, and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect True Nature Holding, Inc. is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.

 

 

 

 

EX-99.2 4 ex_131451.htm EXHIBIT 99.2 ex_131451.htm

 

Exhibit 99.2

 

 

 

 

True Nature Holding, Inc. Expands Board, Adding Experienced Public Equities and Health Care Executive as Chairman

 

Atlanta, GA - (NewMediaWire) - December 04, 2018 - True Nature Holding, Inc. (OTCQB: TNTY) (the "Company" or "True Nature") announces the appointment of Mr. Ronald Riewold as Chairman of its Board of Directors. 

 

Mr. Riewold, 71, contributes extensive senior leadership experience in managing, operating, and growing both public and private companies. Mr. Riewold has been a top executive of six companies since 1978, including three in the health care and technology sectors.  

 

“The Company is entering a phase of rapid growth and we need a team that can execute on day one. Ron has both NASDAQ and AMEX company senior management experience, which is key as we position TNTY for an uplist. In health care, he knows at the field-level what the market needs and how to effectively communicate our vision. He is a perfect fit for where we are and more importantly where we want to go,” said True Nature’s President, Jim Crone. “We’ve made it a priority to bring together a team of very accomplished and experienced professionals. We will be making further announcements shortly and expect to have a full slate of well-qualified directors on our Board. We also have an Advisory Board and will continue to add subject matter expertise to assist the Company through these appointments.”

 

Mr. Riewold brings over 35-years of experience as a corporate and entrepreneurial leader in the finance, technology, and health care markets. He has served as Vice President of Corporate Development, COO, President, CEO of organizations including Heart Labs of America, Cyber Care, Pain Care Holdings, and Averlent Corporation – a recently formed group focused on telehealth solutions at the local level.

 

Mr. Riewold commented, “In my view, the public-company platform that TNTY provides could accelerate the growth of early development organizations that need access to capital relatively quickly. We have a team looking for acquisition opportunities to fuel the growth of TNTY working with developing companies in the health care information technology market space. I’m looking forward to collaborating with the management team to help ensure continued success.”

 

Mr. Riewold earned a bachelor’s degree from Florida State University in 1970, and a Master of Business Administration from Temple University, 1979.

 

 

 

 

The Mission of True Nature Holding, Inc.

 

To leverage new technologies and services to improve healthcare and outcome for individuals, their families, and their pets. We believe we can reduce the cost of healthcare while improving the quality of life using Telehealth and Telemedicine Solutions.

 

We are building healthcare applications that focus on patient engagement, care coordination, remote monitoring, data analytics, and may include Blockchain RX™ to provide applications for market participants in healthcare through the encryption of sensitive data.

 

Our approach is to develop these business opportunities as individual "threads" in response to client needs, ultimately creating an end-to-end set of solutions from the end user up to the healthcare provider, or veterinary professional. Further, we expect to assist suppliers to the healthcare industry by allowing them to access unique technologies that bind them with their clients in a "top-down" distribution model.

 

We recognize it will take the investment of major market participants like Apple, Amazon, IBM, hospitals, healthcare networks, pharmacy and other providers for us to achieve critical mass. In consideration of this reality, we expect to work with these market makers in collaboration, and in support of the ultimate user, the individual, and their pets. The day of "direct-to-consumer" healthcare, including "the humanization of our pets" is upon us, and we hope to be key parties to their evolution, and success.

 

Statement Under the Private Securities Litigation Reform Act

 

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release contains forward-looking statements pertaining to future, anticipated, or projected plans, performances, and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect True Nature Holding, Inc. is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.

 

 

 

GRAPHIC 5 ex_131451img001.jpg begin 644 ex_131451img001.jpg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ex_131450img001.jpg begin 644 ex_131450img001.jpg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end GRAPHIC 7 footer.jpg begin 644 footer.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1#T17AI9@ 34T *@ @ ! $[ ( M . (2H=I 0 ! (6)R= $ < 0T.H< < @, /@ M FMC.60G/SX-"CQX.GAM M<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS M.G)D9CTB:'1T<#HO+W=W=RYW,RYO&UL;G,Z M#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" * M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP86-K M970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q ,$1@5 M&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$'" @* M"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@ +@,J P$B (1 0,1 ?_$ !\ $% 0$! M 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ !?0$" M P $$042(3%!!A-180'EZ@X2% MAH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A,082 M05$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3 ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+C MY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^@/^$@T;_H+V'_@2G^-' M_"0:-_T%[#_P)3_&OFG^RM1_Y\+K_ORW^%']E:C_ ,^%U_WY;_"OH/[)I?\ M/P^5_MRM_P ^OS/I;_A(-&_Z"]A_X$I_C1_PD&C?]!>P_P# E/\ &OFG^RM1 M_P"?"Z_[\M_A1_96H_\ /A=?]^6_PH_LFE_S\#^W*W_/K\SZ6_X2#1O^@O8? M^!*?XT?\)!HW_07L/_ E/\:^:?[*U'_GPNO^_+?X4?V5J/\ SX77_?EO\*/[ M)I?\_ _MRM_SZ_,^EO\ A(-&_P"@O8?^!*?XT?\ "0:-_P!!>P_\"4_QKYI_ MLK4?^?"Z_P"_+?X4?V5J/_/A=?\ ?EO\*/[)I?\ /P/[P_\"4_QKYI_LK4?^?"Z_[\M_A1 M_96H_P#/A=?]^6_PH_LFE_S\#^W*W_/K\SZ6_P"$@T;_ *"]A_X$I_C1_P ) M!HW_ $%[#_P)3_&OFG^RM1_Y\+K_ +\M_A1_96H_\^%U_P!^6_PH_LFE_P _ M _MRM_SZ_,^EO^$@T;_H+V'_ ($I_C1_PD&C?]!>P_\ E/\:^:?[*U'_GPN MO^_+?X4?V5J/_/A=?]^6_P */[)I?\_ _MRM_P ^OS/I;_A(-&_Z"]A_X$I_ MC1_PD&C?]!>P_P# E/\ &OFG^RM1_P"?"Z_[\M_A1_96H_\ /A=?]^6_PH_L MFE_S\#^W*W_/K\SZ6_X2#1O^@O8?^!*?XT?\)!HW_07L/_ E/\:^:?[*U'_G MPNO^_+?X4?V5J/\ SX77_?EO\*/[)I?\_ _MRM_SZ_,^DF\4^'U8JVNZ8".H M-Y'Q^M)_PE?AW_H/:7_X&1_XU\W?V5J/_/A=?]^6_P */[*U'_GPNO\ ORW^ M%/\ LFE_/^0O[TO_P #(_\ &C_A*_#O_0>TO_P,C_QKYN_LK4?^?"Z_[\M_A1_96H_\ M^%U_WY;_ H_LFE_/^0?VY7_ .??YGTC_P )7X=_Z#VE_P#@9'_C1_PE?AW_ M *#VE_\ @9'_ (U\W?V5J/\ SX77_?EO\*/[*U'_ )\+K_ORW^%']DTOY_R# M^W*__/O\SZ1_X2OP[_T'M+_\#(_\:/\ A*_#O_0>TO\ \#(_\:^;O[*U'_GP MNO\ ORW^%']E:C_SX77_ 'Y;_"C^R:7\_P"0?VY7_P"??YGTC_PE?AW_ *#V ME_\ @9'_ (T?\)7X=_Z#VE_^!D?^-?-W]E:C_P ^%U_WY;_"C^RM1_Y\+K_O MRW^%']DTOY_R#^W*_P#S[_,^D?\ A*_#O_0>TO\ \#(_\:/^$K\._P#0>TO_ M ,#(_P#&OF[^RM1_Y\+K_ORW^%']E:C_ ,^%U_WY;_"C^R:7\_Y!_;E?_GW^ M9](_\)7X=_Z#VE_^!D?^-'_"5^'?^@]I?_@9'_C7S=_96H_\^%U_WY;_ H_ MLK4?^?"Z_P"_+?X4?V32_G_(/[TO_P #(_\ &OF[^RM1_P"?"Z_[\M_A1_96H_\ /A=?]^6_PH_L MFE_/^0?VY7_Y]_F?2/\ PE?AW_H/:7_X&1_XT?\ "5^'?^@]I?\ X&1_XU\W M?V5J/_/A=?\ ?EO\*/[*U'_GPNO^_+?X4?V32_G_ "#^W*__ #[_ #/I'_A* M_#O_ $'M+_\ R/_ !H_X2OP[_T'M+_\#(_\:^;O[*U'_GPNO^_+?X4?V5J/ M_/A=?]^6_P */[)I?S_D']N5_P#GW^9](_\ "5^'?^@]I?\ X&1_XT?\)7X= M_P"@]I?_ (&1_P"-?-W]E:C_ ,^%U_WY;_"C^RM1_P"?"Z_[\M_A1_9-+^?\ M@_MRO_S[_,^D?^$K\._]![2__ R/_&C_ (2OP[_T'M+_ / R/_&OF[^RM1_Y M\+K_ +\M_A1_96H_\^%U_P!^6_PH_LFE_/\ D']N5_\ GW^9](_\)7X=_P"@ M]I?_ (&1_P"-'_"5^'?^@]I?_@9'_C7S=_96H_\ /A=?]^6_PH_LK4?^?"Z_ M[\M_A1_9-+^?\@_MRO\ \^_S/I'_ (2OP[_T'M+_ / R/_&C_A*_#O\ T'M+ M_P# R/\ QKYN_LK4?^?"Z_[\M_A1_96H_P#/A=?]^6_PH_LFE_/^0?VY7_Y] M_F?2/_"5^'?^@]I?_@9'_C1_PE?AW_H/:7_X&1_XU\W?V5J/_/A=?]^6_P * M/[*U'_GPNO\ ORW^%']DTOY_R#^W*_\ S[_,^D?^$K\._P#0>TO_ ,#(_P#& MC_A*_#O_ $'M+_\ R/_ !KYYL_"NOW[ 6FCWK@_Q>2RK^9XKL]$^#FHS[9M M?NXK& N :I>)?%%AX8L//O7WRL/W-NI^:0_P!!ZFN6O?%GAGP/H[:? MX82&YN1QMB.Y=W]YW_B^@/MQ7E.I:G>:Q?R7FHSM//(>6;L/0#L/:O'GR\WN M;'T%/GY5S[^1;\0^([_Q+J)NM0DX&1%"OW(AZ ?U[UE445)84444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% '7?\+/\4_\_L?_ (#I_A1_PL_Q3_S^Q_\ @.G^%MW+Q6GEHD2 M&2::9ML<2#JS'T_6@#>_X6?XI_Y_8_\ P'3_ H_X6?XI_Y_8_\ P'3_ K( ME\/2+I_V^UO;6\LDE$4\\/F8@)Q@NK(&P<]0".".O%67\*;-'CU1];TT64DI MA67;/RX&<8\K/;TH O?\+/\ %/\ S^Q_^ Z?X4?\+/\ %/\ S^Q_^ Z?X5CQ M>'IO[,BU"_N[73K:.?N].N* -C_A9_BG_G]C_P# =/\ "GI\4O$ZKAKB!_=H%_I6 M++X:O([_ $ZW26WEBU-U2TNHW)BDR0I[;A@G!! (]*L7'A&ZBBU%K:]L[R33 M"1=Q0F0-'@D$_.B@@$'H30!J?\+4\3?\];;_ +\"C_A:GB;_ )ZVW_?@5Q@& M6 )Q[GM70)X4WZ/)JB:WIILHY1"TNV?AR,XQY6>_I0!I_P#"U/$W_/6V_P"_ M H_X6IXF_P">MM_WX%8MUX7OK;PU#KJO#/932-&&B+%EPQ7VZW$)?S6RI[':AP?T]Z -G_ (6IXF_YZVW_ 'X%'_"U M/$W_ #UMO^_ JA<>#9+771H\^LZ8E\75/+)F !89'S>7CG([]ZJ0>%M0)O^>MM_P!^!7&4 M4 =G_P +4\3?\];;_OP*/^%J>)O^>MM_WX%<910!V?\ PM3Q-_SUMO\ OP*/ M^%J>)O\ GK;?]^!7&44 =G_PM3Q-_P ];;_OP*/^%J>)O^>MM_WX%<910!V? M_"U/$W_/6V_[\"C_ (6IXF_YZVW_ 'X%<910!V?_ M3Q-_SUMO^_ H_X6IX MF_YZVW_?@5QE% '9_P#"U/$W_/6V_P"_ H_X6IXF_P">MM_WX%<910!V?_"U M/$W_ #UMO^_ H_X6IXF_YZVW_?@5QE% '9_\+4\3?\];;_OP*5?BMXE5@2]J MP]##U_(UQ=6/L-Q_9HO_ "_]%,WD^9N'W\;L8Z].] '8?\+:\1?W++_OR?\ MXJC_ (6UXB_N67_?D_\ Q5(O[EE_WY/_Q5<=8V-QJ5]%:64?F3 MRG")N R?J>*@H [C_A;7B+^Y9?\ ?D__ !5'_"VO$7]RR_[\G_XJN'HH [C_ M (6UXB_N67_?D_\ Q5'_ MKQ%_(O[EE_WY/\ \57#T4 =Q_PMKQ%_(O[EE_P!^3_\ %5P] M% 'P.>O08KF** .ML9H?#OA+68+RXMIKO4PD,-O M;SI-M53DNS(2 /FX&2O7'O7+44 M=?K'D^)-!T633[RU2>QM5M)[:YN4A92O1QO(# ^Q]*#)#J?@2'1$NK6'4--N MWEO9+72Q?:E:7R):(L"6[*3;I@81\ 88>^?K6A:W=LOPLO;1KB(7 M+:DKK"7&\KL'(7KCWKEJ* .X@\16^E^&/#,9>.ZA*7D.H6:N"QB>0<$9X..0 M>.E0>/YM/=-$@TF]BO(;:R$0='#$ 'C0RRSQF6_6)EW/*H55,F.,E"Z_B*U-5\00'3SKUC-%%JNHF*.6%&R\/E, M23QT#;(?3.#7$44 >BM-H-XS:6U]!%::H3J4LC.H\B0LA$1/8A1(,=ZC>S11W&G7,EY8I.PRVY"%C4?[++$<#W^M43( R Y7.>=O!(KAZ* .^BU94\1:5 M)=F.-[>WNP;NXU.&\>3,3;5=U '!. &Z[L50L=0&KV^C?VSK4L5Q%?3J;HW& M)HX_+C*_.>0"V0&/ R?0UR%% 'I":S!::OX:N)M0*S++/%=R/J*74@C)4H)) M4 !7)) / Y]*Y\K>_C994570@2EMN1O'&8 MHC)(D!63L>W#=,\=:BTF^9+;1O[-U2ULM/A4C4K>6=4+ON)90R;0,!NF M.,5Q-% ';VVHZ6L^BM!+;Q1QSWQA68@BW9O]2SCG #;3D^F>U6;'4)HH]#&N MZO;W%Q'K E9FODG,<6T#+,&.!D'J>*\_HH [*PUZ2PT?PS;V>I?9P+N1KM(Y M0I"^8N-_^S@MP>#4Z7&%,/AG4+6P*ZG*;H"Y2'SH]W[H@DC?&%W#:,]3QS7# M5>L-9N],4?8Q;*P?S%DDM(I'5N.0S*2.G8\4 :VKP6Z>,;^^O986MDUETEM] MV9&3S"2=O]W (SZFM.2]E'B^WN-8U6WN]'%TS0(MTLL48*GRSY(8E ..JC'2 MN*DD>61I)79W^N1JL$EM(+M)S @;] MZQ<$A4(V_*3VS@8S56?Q/??V9K6S5I/-2^C^R%9OF2,^9N\H]57A!\N!C Z& MN/HH U_%-REYX@DN(Y4E\V&!G=""& GRAPHIC 8 header.jpg begin 644 header.jpg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end